Skip to the reference

Reference desk / Entry

Retatrutide

Also listed as: LY3437943

Read the scope first. Then use the note and questions to examine what the evidence can answer.

Scoped product status
Investigational
Evidence label
Randomized evidence
Status as of

Reference fields

References for these fields are listed together in Sources.

Product and use scope
Investigational; no FDA-approved product.
Route context
Studied as a subcutaneous injection.
Mechanism
Activates GIP, GLP-1 and glucagon receptors.
Evidence
A randomized obesity trial was funded by Lilly.
Limitations
Trial averages do not predict an individual outcome.
Safety
The trial reported gastrointestinal adverse events.

A question worth making clear

If a report combines information from several settings, consider both the combined question and the contribution of each setting. Look for how the parts were brought together and whether the combined answer is the one your discussion needs. Ask what would be lost if the summary were read as though it described every setting equally. A pooled answer may be the intended target, while a question about one setting requires a different examination. Keeping those targets distinct lets readers discuss the combined result without assuming that it describes each contributing situation.

  1. Are we asking about the combined evidence or about one particular setting?
  2. How does each setting contribute to the combined answer presented here?
  3. What information would we need before applying that answer to a single setting?

Sources

Each date below belongs to the supplied source record. The references support the entry as a group.